Form SC 13G Innovation Pharmaceutica Filed by: Kip
Post# of 72440
BY 10K Wizard
— 4:46 PM ET 02/11/2021
http://archive.fast-edgar.com/20210211/AL2TF2...L4Z222Z232
Filed on: February 11, 2021
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,978,229 shares of Common Stock Class A
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ☐
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.37%
http://archive.fast-edgar.com/20210211/AL2TF2...4Z222Z232/
EDITED IN
https://fintel.io/i/kips-bay-select-lp
=======
Quote:
What Is Schedule 13G?
The Securities and Exchange Commission (SEC) Schedule 13G form is an alternative filing for the Schedule 13D form and is used to report a party's ownership of stock which exceeds 5% of a company's total stock issue. Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements. Schedule 13G can be filed in lieu of the SEC Schedule 13D form as long as the filer meets one of several exemptions.1
Both Schedule 13D and Schedule 13G forms are referred to as "beneficial ownership reports." According to the SEC, a beneficial owner is anyone directly or indirectly shares voting power or investment power. These forms are intended to provide information about individuals who have significant holdings in publicly-traded companies and thus, allow for other investors and other interested parties to make informed decisions about their own investments. The ownership of over 5% of a publicly-traded stock is considered significant ownership and reporting
https://www.investopedia.com/terms/s/schedule13g.asp
==============
imo nice to see .. will be watching to see if retained for the next round of reporting (approx 3 mos from now)
4kids
Quote:
Anyone care to summarize today’s 13G filing and put it in simple/understandable terms???